• Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS)

  • 2025/03/18
  • 再生時間： 18 分
  • ポッドキャスト

Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS)

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the effects of inhaled sedation with sevoflurane for patients with moderate to severe ARDS.

    Related Content:

    • Sevoflurane Sedation in Acute Respiratory Distress Syndrome
    • Inhaled Sedation in Acute Respiratory Distress Syndrome
    続きを読む 一部表示

あらすじ・解説

ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the effects of inhaled sedation with sevoflurane for patients with moderate to severe ARDS.

Related Content:

  • Sevoflurane Sedation in Acute Respiratory Distress Syndrome
  • Inhaled Sedation in Acute Respiratory Distress Syndrome
続きを読む 一部表示

Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS)に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。